Clinical Trials Logo

Filter by:
NCT ID: NCT05254067 Enrolling by invitation - Aneurysm Clinical Trials

Enterprise 2 Vascular Reconstruction Device

Start date: February 28, 2017
Phase:
Study type: Observational

The primary objective of this study is to collect data regarding the effectiveness of using the Enterprise 2 Reconstruction Device in successfully embolizing intracranial aneurysms with wide neck configuration.

NCT ID: NCT05254015 Enrolling by invitation - Clinical trials for Obsessive-Compulsive Disorder

Cognitive Rehabilitation and Exposure Therapy for Geriatric Hoarding

CREST
Start date: November 21, 2022
Phase: N/A
Study type: Interventional

Hoarding disorder (HD) is a chronic, progressive, and debilitating psychiatric condition that leads to devastating personal and public consequences, particularly for older adults. This confirmatory efficacy trial will advance our knowledge of the mechanisms of action in the treatment of HD as well as reduce symptom severity, disability, and community consequences.

NCT ID: NCT05249270 Enrolling by invitation - Anxiety Clinical Trials

Online Parent-Report Evaluation of the Effects of Processed Music

Start date: March 22, 2020
Phase:
Study type: Observational

The study aims to examine effectiveness of the Safe and Sound Protocol (SSP) on sensory, digestive, and eating behaviors in children currently receiving therapy.

NCT ID: NCT05248659 Enrolling by invitation - Clinical trials for Immunoglobulin A Nephropathy

Phase 2/3 Open-Label Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy

Start date: April 5, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

This is a phase 2/3 open-label trial to evaluate the long-term safety, tolerability, and efficacy of sibeprenlimab administered subcutaneously (SC) in subjects with IgAN.

NCT ID: NCT05247281 Enrolling by invitation - Clinical trials for Prosthetic Joint Infection

NGS vs Culture Outcomes for Treatment of PJI

Start date: September 21, 2022
Phase: N/A
Study type: Interventional

This multicenter, randomized controlled trial will compare the use of NGS and traditional culture in directing antimicrobial treatment for patients with periprosthetic joint infection.

NCT ID: NCT05245799 Enrolling by invitation - Hearing Loss Clinical Trials

Hear Me Read 2021 Clinical Trial

Start date: March 25, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate if the effects of in-person speech-language therapy with a novel digital storybook intervention platform (Hear Me Read) improves vocabulary, speech and language, and literacy outcomes in young children who are deaf or hard of hearing compared with in-person therapy alone.

NCT ID: NCT05244187 Enrolling by invitation - Pain Clinical Trials

Study to Evaluate the OrthoCor Active System for Pain Relief

Start date: November 7, 2022
Phase: N/A
Study type: Interventional

This is a prospective, multi-center, randomized, pivotal study to evaluate the OrthoCor Active System in individuals prescribed its use in comparison with the standard of care intervention for pain relief.

NCT ID: NCT05240040 Enrolling by invitation - Metastatic Cancer Clinical Trials

Treat Primary and Metastatic Liver Tumors

Start date: April 26, 2016
Phase:
Study type: Observational

The use of Radiospheres in the management of intrahepatic cholangiocarcinoma is largely unknown and not reported in the medical literature. Methodist Dallas Medical Center has a large volume of IR procedures with Radioembolization and the investigators feel it is imperative to understand the outcomes, risks and benefits of the therapy in order to formulate recommendation to other centers.

NCT ID: NCT05238155 Enrolling by invitation - Clinical trials for Graft Vs Host Disease

Evaluation of the Impact of Reduced Immunosuppression

Start date: October 19, 2021
Phase:
Study type: Observational

Graft-versus-host disease (GVHD) is a life-threatening complication of transplantation. It occurs when the donor graft contains immunologically competent T-cells that recognize the recipient as foreign.

NCT ID: NCT05236595 Enrolling by invitation - Clinical trials for Undiagnosed Diseases

Research for Individualized Therapeutics in Rare Genetic Disease

Start date: November 24, 2021
Phase:
Study type: Observational [Patient Registry]

The purpose of this research study is to identify individuals that have a rare genetic disease without an adequate therapeutic strategy that might be treatable with drug developed to target the disease-causing genetic alteration.